Compound made inside human body stops viruses from replicating

Compound made inside human body stops viruses from replicating
A structural model of viperin a naturally occurring enzyme in humans that is known to have antiviral effects on viruses such as West Nile, hepatitis C, rabies, and HIV. A new study led by researchers from Penn State and the Albert Einstein College of Medicine reveals the mode of action of viperin, which facilitates an important reaction that results in the production of ddhCTP, a molecule that prevents viruses from copying their genetic material. Credit: David W. Gohara, Ph.D

The newest antiviral drugs could take advantage of a compound made not by humans, but inside them. A team of researchers has identified the mode of action of viperin, a naturally occurring enzyme in humans and other mammals that is known to have antiviral effects on a wide variety of viruses, including West Nile, hepatitis C, rabies, and HIV.

The enzyme facilitates a reaction that produces the molecule ddhCTP, which prevents viruses from copying their and thus from multiplying. This discovery could allow researchers to develop a drug that induces the human body to produce this molecule and could act as a broad-spectrum therapy for a range of viruses. A paper describing the study appears online on June 20th in the journal Nature.

"We knew viperin had broad antiviral effects through some sort of enzymatic activity, but other antivirals use a different method to stop viruses," said Craig Cameron, professor and holder of the Eberly Chair in Biochemistry and Molecular Biology at Penn State and an author of the study. "Our collaborators at the Albert Einstein College of Medicine, led by senior authors Tyler Grove and Steven Almo, revealed that viperin catalyzes an important reaction that results in the creation of a molecule called ddhCTP. Our team at Penn State then showed the effects of ddhCTP on a 's ability to replicate its genetic material. Surprisingly, the molecule acts in a similar manner to drugs that were developed to treat viruses like HIV and hepatitis C. With a better understanding of how viperin prevents viruses from replicating, we hope to be able to design better antivirals."

A virus typically co-opts the host's genetic building blocks to copy its own genetic material, incorporating called nucleotides into new strands of RNA. The molecule ddhCTP mimics these nucleotide building blocks and becomes incorporated into the virus's genome. Once incorporated into a new strand of the virus's RNA, these "nucleotide analogs" prevent an enzyme called RNA polymerase from adding more nucleotides to the strand, thus preventing the virus from making new copies of its genetic material.

Compound made inside human body stops viruses from replicating
A three-dimensional representation of the Zika virus, which has no known treatments. The molecule ddhCTP halted replication of three different strains of Zika in living cells. These promising results suggest the potential of ddhCTP and similar naturally occurring compounds to be used in future treatments for Zika and other viruses. Credit: Manuel Almagro Rivas
"Long ago, the paradigm was that in order to kill a virus, you had to kill the infected cell," said Cameron. "Such a paradigm is of no use when the virus infects an essential cell type with limited capacity for replenishment. The development of nucleotide analogs that function without actually killing the infected cell changed everything."

Most nucleotide analogs on the market are manmade, but there are often complications with using these synthetic drugs. Because nucleotides are used by many proteins and enzymes of the cell, numerous opportunities exist for analogs to interfere with normal cellular function.

"The major obstacle to developing therapeutically useful antiviral nucleotides is unintended targets," said Jamie Arnold, associate research professor of biochemistry and at Penn State and an author of the paper. "For example, a few years ago we discovered that a nucleotide analog under development for treatment of hepatitis C could interfere with the production of RNA in mitochondria, subcellular organelles important for energy production in the patient's own cells. That meant people with mitochondrial dysfunction are predisposed to any negative effects of this unintended interference."

The molecule ddhCTP, however, does not appear to have any unintended targets. The research team suspects that the natural origin of the compound within the human body necessitates that it be nontoxic.

A team of researchers from Penn State and the Albert Einstein College of Medicine has identified the mode of action of viperin, a naturally occurring enzyme in humans that is known to have antiviral effects on a wide variety of viruses, including West Nile, hepatitis C, rabies, and HIV. Understanding this naturally occurring compound could allow the development of a new broad-spectrum therapy for a range of viruses. Here, Joyce Jose, assistant professor of biochemistry and molecular biology at Penn State and an author of the new study, describes the effect of the compound on Zika virus. Credit: Penn State
"Unlike many of our current drugs, ddhCTP is encoded by the cells of humans and other mammals," said Cameron. "We have been synthesizing nucleotide analogs for years, but here we see that nature beat us to the punch and created a analog that can deal with a virus in living cells and does not exhibit any toxicity to date. If there's something out there that's going to work, nature has probably thought of it first. We just have to find it."

To verify the effectiveness of ddhCTP, the research team showed that the molecule inhibited the RNA polymerases of dengue virus, West Nile virus and Zika virus, which are all in a group of viruses called flaviviruses. Then they investigated whether the molecule halted replication of Zika virus in living cells.

"The molecule directly inhibited replication of three different strains of Zika virus," said Joyce Jose, assistant professor of biochemistry and molecular biology at Penn State and an author of the paper. "It was equally effective against the original strain from 1947 as it was against two strains from the recent 2016 outbreak. This is particularly exciting because there are no known treatments for Zika. This study highlights a new avenue of research into natural compounds like ddhCTP that could be used in future treatments."

Together, these results demonstrate promising antiviral effects of ddhCTP on a variety of flaviviruses. However, the RNA polymerases of human rhinovirus and poliovirus, which are in a group called picornaviruses, were not sensitive to the molecule. The researchers plan to investigate the polymerase structures of these viruses to better understand why flaviviruses are sensitive to ddhCTP while the picornaviruses tested in this study are not. This investigation may also offer insights into how flaviviruses might develop resistance to the molecule.

"Development of resistance to an antiviral agent is always an issue," said Cameron, "Having some idea of how resistance happens, or being able to prevent it from happening, will be critical if this is to be used as a broad-spectrum therapy."


Explore further

Identifying the mechanism for a new class of antiviral drugs could hasten their approval

More information: Anthony S. Gizzi et al, A naturally occurring antiviral ribonucleotide encoded by the human genome, Nature (2018). DOI: 10.1038/s41586-018-0238-4
Provided by Pennsylvania State University
Citation: Compound made inside human body stops viruses from replicating (2018, June 20) retrieved 19 March 2019 from https://medicalxpress.com/news/2018-06-compound-human-body-viruses-replicating.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1026 shares

Feedback to editors

User comments

Jun 21, 2018
It is interesting that scientists have been "synthesizing nucleotide analogs for years" while nature already contained what was needed to slow down or halt the replication of these deadly viruses.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more